Jim Wiehl (US)

Subscribe to all posts by Jim Wiehl (US)

CMS abandons plans to test new Medicare Part B drug reimbursement model

By Jim Wiehl (US) and Mark Faccenda (US) on December 22, 2016 Posted in Regulatory

CMS announced on December 15, 2016 that it will not pursue its plans to finalize a proposed rule that would have created a pilot program to test a new Medicare Part B prescription drug reimbursement model. CMS explained that while the rule garnered some support, numerous stakeholders “expressed strong concerns” about the proposed reimbursement model. … Continue reading

Company exec can face $18M in restitution for ignoring attorney warnings

By Carol Poindexter (US), Jim Wiehl (US) and Savannah Wiseman (US) on March 21, 2016 Posted in Enforcement

On March 3rd, the Ninth Circuit ruled that the president of Commerce Planet, Inc. could be held personally liable for violations of the Federal Trade Commission Act (FTC Act) after he ignored warnings from his in-house counsel that the company’s disclosures about the monthly fees for an online auction kit were inadequate under the FTC Act. … Continue reading

CMS revisits ACO benchmarking

By Jim Wiehl (US) and Joseph Keillor (US) on February 1, 2016 Posted in General, Regulatory

CMS issued a proposed rule on January 28, 2016 that would significantly overhaul benchmark calculations for Medicare Shared Savings Program Accountable Care Organizations (MSSP ACOs), which may increase the long-term attractiveness of the MSSP for high-performing ACOs.… Continue reading

CMS and OIG finalize rules on MSSP ACO waivers

By Jim Wiehl (US) on October 28, 2015 Posted in Regulatory

On October 28, 2015, CMS and OIG jointly issued a final rule for the Medicare Shared Savings Program ACO waivers, which is slated for publication in the Federal Register on October 29. The ACO waivers have been in place since an interim final rule with comment period (IFC) was published on November 2, 2011, and … Continue reading